We are live on ! Find out more
NME

Notis-McConarty Edward Portfolio holdings

AUM $231M
1-Year Est. Return 35.87%
This Fund
S&P 500
This Quarter Est. Return
+1.08%
1 Year Est. Return
+35.87%
3 Year Est. Return
+91.2%
5 Year Est. Return
+121.34%
10 Year Est. Return
+412.66%
AUM
$143M
AUM Growth
+$839K
Cap. Flow
+$161K
Cap. Flow %
0.11%
Top 10 Hldgs %
31.34%
Holding
112
New
1
Increased
21
Reduced
39
Closed
1

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$422K
2
FISV
Fiserv Inc
FISV
+$386K
3
GSK icon
GSK
GSK
+$366K
4
XLNX
Xilinx Inc
XLNX
+$229K
5
CVX icon
Chevron
CVX
+$207K

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceutical Industries Limited
TEVA
+$690K
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$241K
3
SU icon
Suncor Energy
SU
+$193K
4
CNI icon
Canadian National Railway
CNI
+$146K
5
MMM icon
3M
MMM
+$128K

Sector Composition

Rank Sector Weight
1 Healthcare 23.51%
2 Technology 19.88%
3 Industrials 17.5%
4 Energy 12.63%
5 Consumer Staples 9.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
26
Amgen
AMGN
$203B
$1.94M 1.35%
15,721
-200
-1% -$24.3K
GSK icon
27
GSK
GSK
$100B
$1.89M 1.31%
28,216
+5,420
+24% +$366K
AAPL icon
28
Apple
AAPL
$4.84T
$1.66M 1.15%
86,408
+1,400
+2% +$26.6K
JCI icon
29
Johnson Controls International
JCI
$83.8B
$1.64M 1.14%
33,138
+405
+1% +$20.5K
WFC icon
30
Wells Fargo
WFC
$271B
$1.61M 1.12%
32,435
-100
-0.3% -$4.66K
ORCL icon
31
Oracle
ORCL
$424B
$1.54M 1.07%
37,705
– –
HP icon
32
Helmerich & Payne
HP
$4.34B
$1.53M 1.07%
14,245
+470
+3% +$43.7K
AFL icon
33
Aflac
AFL
$58.9B
$1.43M 1%
45,348
-1,000
-2% -$31.8K
CELG
34
DELISTED
Celgene Corp
CELG
$1.4M 0.97%
20,010
– –
FISV
35
Fiserv Inc
FISV
$26.6B
$1.32M 0.92%
46,720
+13,480
+41% +$386K
HON icon
36
Honeywell
HON
$64.5B
$1.3M 0.91%
15,636
– –
MRK icon
37
Merck
MRK
$355B
$1.25M 0.87%
23,087
-210
-0.9% -$10.9K
JPM icon
38
JPMorgan Chase
JPM
$937B
$1.21M 0.84%
19,961
-1,240
-6% -$71.7K
CB
39
DELISTED
CHUBB CORPORATION
CB
$1.2M 0.84%
13,440
-100
-0.7% -$8.76K
MCD icon
40
McDonald's
MCD
$179B
$1.19M 0.83%
12,163
-100
-0.8% -$9.56K
TGT icon
41
Target
TGT
$70.1B
$1.09M 0.76%
17,970
+1,450
+9% +$85.9K
DD
42
DELISTED
Du Pont De Nemours E I
DD
$1.08M 0.75%
16,953
-211
-1% -$12.9K
DE icon
43
Deere & Co
DE
$184B
$1.06M 0.74%
11,622
-1,150
-9% -$101K
COV
44
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$1.05M 0.73%
14,283
– –
PBA icon
45
Pembina Pipeline
PBA
$27.5B
$1.04M 0.72%
27,222
– –
KO icon
46
Coca-Cola
KO
$382B
$997K 0.69%
25,800
– –
VZ icon
47
Verizon
VZ
$214B
$995K 0.69%
20,916
-100
-0.5% -$4.73K
LOW icon
48
Lowe's Companies
LOW
$109B
$950K 0.66%
19,435
– –
NXPI icon
49
NXP Semiconductors
NXPI
$57.1B
$941K 0.66%
16,000
-500
-3% -$26.1K
SYY icon
50
Sysco
SYY
$38.2B
$829K 0.58%
22,935
-500
-2% -$18K
1
2
3 4 5

Similar funds

PFSC
Peoples Financial Services Corp Moosic, Pennsylvania $231M AUM 37.59% 1-Year Est. Return
ACM
Accent Capital Management Centerville, Ohio $231M AUM 33.86% 1-Year Est. Return
GPW
Gray Private Wealth Canton, Massachusetts $231M AUM 21.48% 1-Year Est. Return
LV
Lifeyrissjodur Verzlunarmanna Reykjavik $231M AUM 20.57% 1-Year Est. Return
NA
N10 Assets Greenwich, Connecticut $231M AUM
FFG
Foundry Financial Group Laconia, New Hampshire $231M AUM 22.2% 1-Year Est. Return
SF
Steffes Financial Overland Park, Kansas $232M AUM
VH
VVR Holdings Bellingham, Washington $231M AUM

Notis-McConarty Edward's Q1 2014 Portfolio in Review

As of Q1 2014, Notis-McConarty Edward held 112 positions worth $143M, up 0.59% from $143M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Trading was light in Q1 2014: portfolio turnover was 1.8%. Notis-McConarty Edward opened 1 new position and exited 1, leaving the 112-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.

  • Notis-McConarty Edward's largest Q1 2014 buy was Xilinx Inc: 4,600 shares worth $250K.
  • Notis-McConarty Edward added most to Qualcomm in Q1 2014, an estimated $422K increase.
  • Notis-McConarty Edward's biggest Q1 2014 reduction was Alnylam Pharmaceuticals, cutting an estimated $241K.
  • Notis-McConarty Edward fully exited Teva Pharmaceutical Industries Limited in Q1 2014, selling an estimated $690K.
  • Notis-McConarty Edward's ten largest holdings make up 31% of its $143M portfolio in Q1 2014.
  • Notis-McConarty Edward opened 1 new position and closed 1 in Q1 2014.
  • Notis-McConarty Edward's portfolio value rose 0.59% quarter-over-quarter to $143M.

Based on Notis-McConarty Edward's 13F filing for Q1 2014, filed 29 May 2014.